Lyophilized recombinant tuberculosis vaccine (Anhui Longkema biological)
冻干重组结核疫苗（安徽龙科马生物）
Report date: 2023/12/07 20:00:52
Base Information
Drug NameLyophilized recombinant tuberculosis vaccine (Anhui Longkema biological)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A